ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Chicago, IL, USA:

E3 Diabetes - Closing the Gap in Diabetes Control (E3Diabetes)

This study aims to decrease the racial gap in type 2 diabetes control in African American and Latinx patients in Rush University Medical Cen...

Invitation-only
Type 2 Diabetes
Behavioral: E3 Self-Guided Type 2 Diabetes Education
Behavioral: E3 Multidisciplinary Team
Rush
Rush

Chicago, Illinois, United States

inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 ...

Enrolling
Diabetic Nephropathies
Diabetes Mellitus Type 1
Drug: Placebo
Drug: Sotagliflozin

Phase 3

Alessandro Doria

Chicago, Illinois, United States and 17 other locations

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Enrolling
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Chicago, Illinois, United States and 26 other locations

Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...

Active, not recruiting
Recent Onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 2

Dompé
Dompé

Chicago, Illinois, United States and 56 other locations

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Enrolling
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Chicago, Illinois, United States and 5 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Chicago, Illinois, United States and 55 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Evanston, Illinois, United States and 64 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

Chicago, Illinois, United States and 42 other locations

transplantation in improving glycemic control in Type 1 diabetic patients using the UIC protocol that was developed and proven effective du...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Islets of Langerhans transplantation

Phase 3

CellTrans

Chicago, Illinois, United States

standard of care versus standard of care only in the treatment of diabetic foot ulcers. The trial design will control potential variables th...

Enrolling
Diabetic Foot Ulcer
Other: Standard Care
Other: BR-AC
BioStem Technologies

North Chicago, Illinois, United States and 9 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems